Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Work In Process: 2021-2024

Historic Work In Process for Organogenesis Holdings (ORGO) over the last 4 years, with Dec 2024 value amounting to $923,000.

  • Organogenesis Holdings' Work In Process rose 9.57% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 9.57%. This contributed to the annual value of $923,000 for FY2024, which is 13.95% up from last year.
  • As of FY2024, Organogenesis Holdings' Work In Process stood at $923,000, which was up 13.95% from $810,000 recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Work In Process ranged from a high of $1.0 million in FY2022 and a low of $810,000 during FY2023.
  • For the 3-year period, Organogenesis Holdings' Work In Process averaged around $918,333, with its median value being $923,000 (2024).
  • In the last 5 years, Organogenesis Holdings' Work In Process declined by 20.74% in 2023 and then climbed by 13.95% in 2024.
  • Organogenesis Holdings' Work In Process (Yearly) stood at $991,000 in 2021, then rose by 3.13% to $1.0 million in 2022, then fell by 20.74% to $810,000 in 2023, then rose by 13.95% to $923,000 in 2024.